MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
Go back to MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction| Miracle Applications Corp (NASDAQ: MIRA) | Delayed: 0.83 +0.07 (9.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.76 | 52 Week High | $0.04 | |||
| Open | $0.79 | 52 Week Low | $0.00 | |||
| Day High | $0.83 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $0.00 | |||
| Volume | 682,603 | |||||
